Annual Long Term Debt
$20.20 M
+$15.56 M+334.98%
December 31, 2023
Summary
- As of February 26, 2025, VRDN annual long term debt is $20.20 million, with the most recent change of +$15.56 million (+334.98%) on December 31, 2023.
- VRDN annual long term debt is now at all-time high.
Performance
VRDN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$20.52 M
+$3.04 M+17.36%
September 30, 2024
Summary
- As of February 26, 2025, VRDN quarterly long term debt is $20.52 million, with the most recent change of +$3.04 million (+17.36%) on September 30, 2024.
- Over the past year, VRDN quarterly long term debt has increased by +$523.00 thousand (+2.62%).
- VRDN quarterly long term debt is now at all-time high.
Performance
VRDN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
VRDN Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +335.0% | +2.6% |
3 y3 years | - | +2.6% |
5 y5 years | +152.4% | +2.6% |
VRDN Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +335.0% | at high | +347.6% |
5 y | 5-year | at high | +366.8% | at high | +505.6% |
alltime | all time | at high | >+9999.0% | at high | +1375.4% |
Viridian Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $20.52 M(+17.4%) |
Jun 2024 | - | $17.49 M(-14.0%) |
Mar 2024 | - | $20.33 M(+0.6%) |
Dec 2023 | $20.20 M(+335.0%) | $20.20 M(+1.0%) |
Sep 2023 | - | $20.00 M(+324.7%) |
Jun 2023 | - | $4.71 M(+0.7%) |
Mar 2023 | - | $4.68 M(+0.7%) |
Dec 2022 | $4.64 M(+7.3%) | $4.64 M(+0.7%) |
Sep 2022 | - | $4.61 M(+0.6%) |
Jun 2022 | - | $4.58 M(+11.1%) |
Sep 2020 | - | $4.13 M(-23.3%) |
Jun 2020 | - | $5.38 M(+58.7%) |
Mar 2020 | - | $3.39 M(-21.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $4.33 M(-45.9%) | $4.33 M(-17.7%) |
Sep 2019 | - | $5.26 M(-14.9%) |
Jun 2019 | - | $6.18 M(-12.9%) |
Mar 2019 | - | $7.09 M(-11.4%) |
Dec 2018 | $8.00 M(-19.3%) | $8.00 M(-10.2%) |
Sep 2018 | - | $8.91 M(-9.2%) |
Jun 2018 | - | $9.82 M(-2.0%) |
Mar 2018 | - | $10.02 M(+1.0%) |
Dec 2017 | $9.92 M(>+9900.0%) | $9.92 M(+613.3%) |
Sep 2017 | - | $1.39 M(-25.7%) |
Jun 2017 | - | $1.87 M(-20.3%) |
Mar 2017 | - | $2.35 M |
Dec 2012 | $42.00 K | - |
FAQ
- What is Viridian Therapeutics annual long term debt?
- What is the all time high annual long term debt for Viridian Therapeutics?
- What is Viridian Therapeutics annual long term debt year-on-year change?
- What is Viridian Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly long term debt year-on-year change?
What is Viridian Therapeutics annual long term debt?
The current annual long term debt of VRDN is $20.20 M
What is the all time high annual long term debt for Viridian Therapeutics?
Viridian Therapeutics all-time high annual long term debt is $20.20 M
What is Viridian Therapeutics annual long term debt year-on-year change?
Over the past year, VRDN annual long term debt has changed by +$15.56 M (+334.98%)
What is Viridian Therapeutics quarterly long term debt?
The current quarterly long term debt of VRDN is $20.52 M
What is the all time high quarterly long term debt for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly long term debt is $20.52 M
What is Viridian Therapeutics quarterly long term debt year-on-year change?
Over the past year, VRDN quarterly long term debt has changed by +$523.00 K (+2.62%)